Y-Intercept (HK)’s Definium Therapeutics DFTX Stock Holding History

Y-Intercept (HK)’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$609K	Sell	16,000 -38,466	-71%	-$1.62M	0.01%	1222
2026 Q2	$2.56M	Buy	+54,466	New	+$1.35M	0.05%	565
2024 Q2	–	Sell	-23,316	Closed	-$219K	–	1716
2024 Q1	$219K	Buy	23,316 +6,463	+38%	+$36.9K	0.02%	1104
2023 Q4	$61.7K	Buy	+16,853	New	+$50.7K	0.01%	1143
2022 Q3	–	Sell	-9,806	Closed	-$94K	–	1158
2022 Q2	$94K	Buy	+9,806	New	+$124K	0.01%	723

Other funds holding DFTX

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

Stableford Capital II Scottsdale, Arizona $288M AUM 21.3% 1-Year Est. Return

Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Diversify Advisory Services Sandy, Utah $6.69B AUM 18.85% 1-Year Est. Return

Diversify Wealth Management Sandy, Utah $6.69B AUM 22.4% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

FSBI

Fearless Solutions (Best Invest) San Antonio, Texas $197M AUM 23.54% 1-Year Est. Return

Y-Intercept (HK)'s DFTX Position: Q3 2026 in Review

Y-Intercept (HK) reduced its Definium Therapeutics (DFTX) stake by 71% in Q3 2026, selling an estimated $1.62M and leaving 16,000 shares worth $609K. The position accounts for 0.01% of the portfolio, ranked #1222.

Y-Intercept (HK) first reported a position in DFTX in Q2 2022 and has held it in 5 quarters since. The position peaked at $2.56M in Q2 2026. 42 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.

Y-Intercept (HK) held 16,000 shares of Definium Therapeutics worth $609K as of Q3 2026.
Y-Intercept (HK) sold 38,466 Definium Therapeutics shares in Q3 2026, an estimated $1.62M.
Definium Therapeutics made up 0.01% of Y-Intercept (HK)'s portfolio in Q3 2026, its #1222 holding.
Y-Intercept (HK) first reported a position in Definium Therapeutics in Q2 2022 and has held it in 5 quarters since.
Y-Intercept (HK)'s Definium Therapeutics position peaked at $2.56M in Q2 2026.
42 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.